Article
- The EMBO Journal (2003) 22, 1824 - 1834
- doi:10.1093/emboj/cdg181
Subject Categories:
Structural basis for antibiotic recognition by the TipA class of multidrug-resistance transcriptional regulators
Jan D. Kahmann1, Hans-Jürgen Sass1, Martin G. Allan1, Haruo Seto2, Charles J. Thompson3 and Stephan Grzesiek1
- Division of Structural Biology, Biozentrum der Universität Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland
- Department of Applied Biology and Chemistry, Faculty of Applied Bio-Science, Tokyo University of Agriculture, Tokyo, Japan
- Division of Microbiology, Biozentrum der Universität Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland
Correspondence to:
Hans-Jürgen Sass, E-mail: juergen.sass@unibas.ch
Charles J. Thompson, E-mail: charles-j.thompson@unibas.ch
Stephan Grzesiek, E-mail: stephan.grzesiek@unibas.ch
Received 18 December 2002; Accepted 24 February 2003; Revised 21 February 2003
Abstract
The TipAL protein, a bacterial transcriptional regulator of the MerR family, is activated by numerous cyclic thiopeptide antibiotics. Its C-terminal drug-binding domain, TipAS, defines a subfamily of broadly distributed bacterial proteins including Mta, a central regulator of multidrug resistance in Bacillus subtilis. The structure of apo TipAS, solved by solution NMR [Brookhaven Protein Data Bank entry 1NY9], is composed of a globin-like
-helical fold with a deep surface cleft and an unfolded N-terminal region. Antibiotics bind within the cleft at a position that is close to the corresponding heme pocket in myo- and hemoglobin, and induce folding of the N-terminus. Thus the classical globin fold is well adapted not only for accommodating its canonical cofactors, heme and other tetrapyrroles, but also for the recognition of a variety of antibiotics where ligand binding leads to transcriptional activation and drug resistance.
Keywords:
- antibiotic recognition,
- globin fold,
- heteronuclear NMR,
- protein dynamics,
- transcriptional regulation



